U.S. Markets close in 5 hrs 26 mins

Free Research Report as Exponent's Quarterly Earnings Advanced 30.77%

LONDON, UK / ACCESSWIRE / July 24, 2018 / If you want access to our free earnings report on Exponent, Inc. (NASDAQ: EXPO), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=EXPO. The Company reported its financial results on July 19, 2018, for the second quarter of the fiscal year 2018, ended June 29, 2018. The Company surpassed analysts' consensus estimates for earnings and revenues in Q2 FY18. Register today and get access to over 1,000 Free Research Reports by joining our site below:


Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Exponent most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:


Earnings Highlights and Summary

For Q2 FY18, Exponent's total revenues reached $95.62 million, reflecting an increase of 8.86% from $87.84 million in Q2 FY17. The Company's total revenue numbers exceeded analysts' consensus estimates by $2.87 million.

Exponent's results for Q2 FY18 reflected a continuing demand for its expertise and services, supported by a positive market trends across several industries, practices, and geographies, and consistent with the expected step-down in the ongoing large human factors project.

During the quarter under review, Exponent's revenues before reimbursements increased 6.96% to $89.97 million on a y-o-y basis, while its reimbursements advanced 51.85% to $5.65 million on a y-o-y basis.

Exponent incurred total operating expenses of $73.14 million in Q2 FY18, up 8.32% from $67.52 million in Q2 FY17. For the reported quarter, the Company's compensation and related expenses advanced 7.61% to $55.46 million on a y-o-y basis, while its other operating expenses jumped 4% to $7.57 million on a y-o-y basis. The Company's reimbursable expenses also increased 51.85% to $5.65 million on a y-o-y basis, and its general and administrative expenses fell 10.46% to $4.47 million on a y-o-y basis in Q2 FY18. Exponent had an operating income of $22.48 million in Q2 FY18 compared to $20.32 million in Q2 FY17, reflecting an increase of 10.64%. On a non-GAAP basis, excluding share-based compensation, the Company had adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) of $29.71 million in the reported quarter, up 9.07% from $27.24 million in the year ago same quarter.

For the quarter ended June 29, 2018, Exponent's net income was $18.43 million, up 33.60% from $13.79 million in the comparable period of last year. The Company's diluted earnings per share (EPS) also advanced 30.77% to $0.34 in Q2 FY18 from $0.26 in Q2 FY17, and exceeded analysts' consensus estimates by $0.03 per share.

Segment Details

Exponent's Engineering & Other Scientific segment's revenues represented approximately 80% of the Company's total revenues for Q2 FY18 and H1 FY18. The segment's revenues increased 8% on a y-o-y basis in the quarter under review, led by noteworthy performances in its human factors, material sciences, thermal sciences, mechanical engineering, and construction consulting practices.

Exponent's Environmental & Health segment's revenues represented approximately 20% of the Company's total revenues for Q2 FY18 and H1 FY18. The segment's revenues grew 3% on a y-o-y basis in the reported quarter, led by a strong growth in its chemical regulation and food safety practice.

Cash Matters

Exponent had cash and cash equivalents of $117.77 million as on June 29, 2018, 5.63% lower than $124.79 million as on December 29, 2017.

Exponent paid $13.50 million in dividends in the first half of 2018. On June 07, 2018, the Company completed its previously announced two-for-one stock split of its common stock. As of June 29, 2018, Exponent had approximately 52 million shares of common stock outstanding.


For the full fiscal year 2018, Exponent reiterated its revenue growth and increased its margin expectations. The Company now expects revenues before reimbursements to grow in the mid-to-high single digits, and EBITDA margin to decline by approximately 25 to 50 basis points for FY18 compared to FY17. Exponent expects its consolidated income tax rate to be approximately 22% to 23% for FY18, after including the estimated tax adjustments associated with share-based awards.

On July 19, 2018, Exponent's Board of Directors declared a quarterly cash dividend of $0.13 per share of common stock, to be paid on September 21, 2018, to all common stockholders of record as of September 07, 2018. The Company also reiterated its intent of continuing to pay quarterly dividends.

Stock Performance Snapshot

July 23, 2018 - At Monday's closing bell, Exponent's stock rose 1.33%, ending the trading session at $49.50.

Volume traded for the day: 318.20 thousand shares, which was above the 3-month average volume of 228.75 thousand shares.

Stock performance in the last three-month - up 15.38%; previous six-month period - up 34.60%; past twelve-month period - up 51.72%; and year-to-date - up 39.24%

After yesterday's close, Exponent's market cap was at $2.65 billion.

Price to Earnings (P/E) ratio was at 43.16.

The stock has a dividend yield of 1.05%.

The stock is part of the Services sector, categorized under the Management Services industry.


Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.


For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

SOURCE: Active-Investors